Distinct p53 genomic binding patterns in normal and cancer-derived human cells.
about
The transcription factor p53: not a repressor, solely an activatorChanges in human pluripotent stem cell gene expression after genotoxic stress exposuresA p53 drug response signature identifies prognostic genes in high-risk neuroblastomaCistrome plasticity and mechanisms of cistrome reprogrammingCondition-specific target prediction from motifs and expression.Large-scale quality analysis of published ChIP-seq data.Microarray and ChIP-seq data analysis revealed changes in p53-mediated transcriptional regulation in Nutlin-3-treated U2OS cellsA polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection.A PTCH1 homolog transcriptionally activated by p53 suppresses Hedgehog signalingCell context dependent p53 genome-wide binding patterns and enrichment at repeats.Structure-based predictions broadly link transcription factor mutations to gene expression changes in cancers.p53 and cell cycle dependent transcription of kinesin family member 23 (KIF23) is controlled via a CHR promoter element bound by DREAM and MMB complexes.p53 binding to human genome: crowd control navigation in chromatin contextInteractions of chromatin context, binding site sequence content, and sequence evolution in stress-induced p53 occupancy and transactivation.Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma.Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53Mutant p53 cooperates with ETS2 to promote etoposide resistance.Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with DoxorubicinThe common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation.p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) AnalysesGenome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiationp53 regulates the mevalonate pathway in human glioblastoma multiforme.Radiation-induced alternative transcription and splicing events and their applicability to practical biodosimetryRecent discoveries in the cycling, growing and aging of the p53 fieldGlobal genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses.Dachshund binds p53 to block the growth of lung adenocarcinoma cellsNegative control of CSL gene transcription by stress/DNA damage response and p53.Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells.Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks.Local depletion of DNA methylation identifies a repressive p53 regulatory region in the NEK2 promoter.Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cellsRotational positioning of nucleosomes facilitates selective binding of p53 to response elements associated with cell cycle arrest.Transcriptional and post-transcriptional regulation of the ionizing radiation response by ATM and p53NRF2 and p53: Januses in cancer?Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.Neat1 is a p53-inducible lincRNA essential for transformation suppression.Tumorigenesis by Meis1 overexpression is accompanied by a change of DNA target-sequence specificity which allows binding to the AP-1 elementp53-dependent non-coding RNA networks in chronic lymphocytic leukemia.Parallel profiling of the transcriptome, cistrome, and epigenome in the cellular response to ionizing radiation.Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein.
P2860
Q24273295-2DE4513E-601B-4DBE-B425-6819F4085E55Q27000820-40DC3DD1-FE59-445E-9B1F-54B87F5FFF70Q28537647-7355F3B9-B8F5-481E-AF15-2C7CDDA71805Q28727255-3A259622-918A-4E06-AB25-8AC5B23BD27DQ30359009-7791E6AF-2737-4631-8605-4197C2116925Q30717456-3329460E-8EC9-4674-8EFB-A58A966D72A4Q30973420-4146E625-8099-47C6-8E57-9DB2C4B9FF0DQ34228309-39E284CD-A46F-409E-9769-A3AEC45AEFACQ34552825-3F9267EF-3877-4A0A-9252-41EF03066473Q34557184-D326DE48-2609-4D10-9530-83D4E5F9D216Q34579681-1118B544-FAB9-4FDC-94D2-769AEFA8C378Q34708518-E7AEEF4F-2D5F-4D60-B422-149A38EC44B4Q34755812-74D5FB42-6C29-463F-9046-7D0F7B7E9B60Q34873579-8AC29862-6EE0-4773-AD18-813B2ECEF134Q34998769-DDF7F98B-E7CD-4F52-87C4-B31CDBC2C48BQ35196159-AA9AEEAB-6621-4E47-8547-BE04B946F070Q35914917-A2FAF5C0-C4AA-49C9-9A35-1F58A5FD1EADQ35926350-A45B16F2-BA78-498B-BD03-B8D8F6581D1DQ36008822-DEE11FBD-3BEE-47A2-8750-0558F1CB18ACQ36133972-B0CD262C-8D80-45F1-BA2B-0C9851B608DDQ36180219-87773C4E-D871-4767-8CE4-A150AC1E2343Q36246455-BB80FCC7-FFE0-4BAC-A420-8EEDC2DA4C7EQ36499618-BE5EFAD8-32DF-45F9-9303-F5B308264667Q36736358-728A6E63-C8D6-43C6-B1D6-9E86EA747703Q36850426-104B1AC9-D629-4190-8B0E-0762FC59135EQ36906650-85FC07CA-94A6-4D38-9BBD-F1B1E9066FCFQ37118737-7E92BF7B-A237-4AB9-A6E9-71B869B13FCBQ37122075-4D164570-9D41-4329-A125-ACE3B97156D8Q37197461-7B7D1B69-BFC0-4407-9C06-954E7CCEA828Q37388830-C9DE1D6A-5BF7-4D5C-8289-F220DE560EFBQ37417024-26FED14C-2D8C-4CAE-B87E-E6E6F4DBFA58Q37518662-F64BFD9C-6075-4CB9-9D9C-0FED9752ED5FQ37678800-3F59D249-46A8-4D19-9A9B-3A5ED685F090Q38061832-96EEFBFA-9F35-4F6F-90B8-913A065BF962Q38310745-F548E954-9A15-4681-B9F1-A4B901F07831Q38683437-075B3A0F-8D9A-4AC0-86AC-F268D5F64219Q38844877-7B0946AC-CA52-45B1-81CD-9163807327A5Q38875344-B810F013-A9F6-4E74-BC7B-53C2FA902E16Q38995173-8FE4F956-B50B-4685-B0F7-5E9E70EB9715Q39090989-9CD3BF06-B516-4083-8024-0EF660AC990D
P2860
Distinct p53 genomic binding patterns in normal and cancer-derived human cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Distinct p53 genomic binding patterns in normal and cancer-derived human cells.
@ast
Distinct p53 genomic binding patterns in normal and cancer-derived human cells.
@en
type
label
Distinct p53 genomic binding patterns in normal and cancer-derived human cells.
@ast
Distinct p53 genomic binding patterns in normal and cancer-derived human cells.
@en
prefLabel
Distinct p53 genomic binding patterns in normal and cancer-derived human cells.
@ast
Distinct p53 genomic binding patterns in normal and cancer-derived human cells.
@en
P2093
P2860
P356
P1433
P1476
Distinct p53 genomic binding patterns in normal and cancer-derived human cells.
@en
P2093
Carl W Anderson
John J Dunn
Krassimira Botcheva
Sean R McCorkle
P2860
P304
P356
10.4161/CC.10.24.18383
P577
2011-12-15T00:00:00Z